Medication Saxenda
The drug Liraglutide, known commercially as Saxenda, is approved for the management of obesity. This video shows what it consists of, indications, contraindications, side effects, results and recommendations for use.
Read MoreAuthor: Dr. Javier Acuña
Update of management guidelines for patients with obesity.
For more than 30 years, care guidelines for the management of patients with obesity had not been updated.
The 1991 NIH Consensus Statement has been used by providers, hospitals, and insurers as a standard for selection criteria for bariatric surgery. (1) A body mass index (BMI) of 40 kg/m2, or a BMI of 35 kg/m2 with comorbidities, is a threshold for surgery that is universally applied.
Dr Javier Acuña
I am a specialist in General Surgery trained at the Israelita and Italiano Hospitals in Buenos Aires, Argentina. I have dedicated fifteen years of my professional life to the management of patients with obesity, performing minimally invasive surgical procedures that generate little pain and early recovery achieving excellent functional and aesthetic results.